Diabetes

Atrasentan tied to lower risk for kidney events in T2DM with CKD

(HealthDay)—Atrasentan is associated with a reduced risk for renal events in patients with type 2 diabetes and chronic kidney disease, according to a study published online April 14 in The Lancet to coincide with the International ...

Medical research

'Goldilocks' drug prevents chronic kidney disease in primates

Cells in any organ will die if their blood supply is cut off - such as during a heart attack, stroke, or organ transplant - but restoring circulation can also cause damage. Now a Massachusetts General Hospital (MGH) research ...

page 24 from 40